Paraganglioma is a rare tumor that can develop near major blood vessels and nerves throughout your body, most commonly in the head, neck, chest, and abdomen. While these tumors are uncommon, affecting only about 2 out of every million people, proper diagnosis is essential because they can release powerful hormones that affect your blood pressure, heart rate, and other vital functions. Some paragangliomas grow silently without symptoms, while others can cause serious health problems if left untreated.

Introduction: Who Should Undergo Diagnostic Testing

If you experience certain symptoms that cannot be easily explained by other conditions, your doctor may recommend testing for paraganglioma. This is particularly important if you have episodes of high blood pressure that come and go, severe headaches, rapid heartbeat, excessive sweating, or unexplained anxiety. These symptoms occur because some paragangliomas release hormones called catecholamines, which are chemicals that include adrenaline and noradrenaline, into your bloodstream.^[1]

Not everyone with paraganglioma experiences these dramatic symptoms. Some people discover they have a tumor only when it is found accidentally during imaging tests for other health concerns. Paragangliomas in the head and neck region, for example, might cause different symptoms such as a pulsing sound in your ears (called pulsatile tinnitus), trouble swallowing, hoarse voice, hearing loss, blurred vision, or dizziness. These symptoms develop as the tumor grows larger and begins to press on nearby structures.^[2]

You should seek diagnostic evaluation if you have a family history of paraganglioma or related conditions. About 30 to 40 percent of paragangliomas are hereditary, meaning they run in families. Certain genetic syndromes, such as Multiple Endocrine Neoplasia Types 2A and 2B, Von Hippel-Lindau Syndrome, Neurofibromatosis type 1, and Familial Paraganglioma Syndrome, increase your risk of developing these tumors. If a close family member has been diagnosed with paraganglioma or one of these genetic conditions, your doctor may recommend testing even if you have no symptoms.^[3]

Anyone at any age can develop paraganglioma, but these tumors most commonly appear in people between 30 and 50 years of age. About 10 percent of cases occur in children. If you are young and have been diagnosed with high blood pressure that is difficult to control with medication, your doctor might consider paraganglioma as a possible cause, even though it is rare.^[1]

Classic Diagnostic Methods

When your doctor suspects paraganglioma, the diagnostic process typically begins with laboratory tests of your blood and urine. These tests measure the levels of catecholamines or their breakdown products in your body. If a paraganglioma is producing excess hormones, these substances will be elevated. Blood tests can measure catecholamine hormones directly, while urine tests collected over a 24-hour period can detect breakdown products of these hormones. Your doctor may also check for a protein called chromogranin A, which can be elevated when paraganglioma is present.^[9]

Blood and urine testing are essential first steps because they can confirm whether your symptoms are related to excess hormone production. However, these tests may be normal if you have one of the non-secreting types of paraganglioma. In such cases, diagnosis relies more heavily on imaging studies and the presence of symptoms related to the tumor’s location and size.^[3]

Once laboratory tests suggest the possibility of paraganglioma, your healthcare team will recommend imaging tests to locate the tumor and determine its size. Several types of imaging are available, and your doctor will choose the most appropriate ones based on your symptoms, test results, and family history. These imaging studies are crucial because paragangliomas can develop in many different locations throughout your body.^[9]

Magnetic resonance imaging (MRI) uses radio waves and a powerful magnetic field to create detailed images of the inside of your body. MRI is particularly useful for visualizing paragangliomas in the head, neck, and abdomen because it provides excellent detail of soft tissues. This test does not use radiation and can show the relationship between the tumor and surrounding blood vessels, nerves, and organs.^[9]

Computed tomography (CT) scan combines a series of X-ray images taken from various angles around your body and uses computer processing to create cross-sectional images. CT scans are fast and widely available. They are particularly helpful for detecting tumors in the chest and abdomen and for determining if the tumor has spread to other parts of the body.^[9]

Specialized nuclear medicine scans are often used specifically for paraganglioma because these tumors have unique characteristics that make them absorb certain radioactive tracers. A metaiodobenzylguanidine (MIBG) scan involves injecting a small amount of radioactive tracer that is absorbed by paragangliomas. This test is particularly useful because it can detect paragangliomas throughout the entire body in a single scan, including very small tumors or those that have spread to other locations.^[9]

Positron emission tomography (PET) scan is another type of nuclear medicine test that uses different radioactive tracers that are also absorbed by tumor tissue. PET scans can sometimes detect paragangliomas that other imaging methods miss, especially in cases where the tumor is small or located in an unusual place.^[9]

In addition to these imaging studies, your doctor may recommend genetic testing. Because a significant proportion of paragangliomas are hereditary, understanding whether you have a genetic mutation can be important for several reasons. Genetic testing results can help predict the chances of your tumor coming back after treatment. They can also determine whether your family members should be screened for paraganglioma. Scientists have identified approximately 20 different genes that may lead to paraganglioma, including mutations in genes called RET, VHL, NF1, and various SDH genes.^[3]

Your healthcare team may refer you to a genetic counselor who can explain the implications of genetic testing and help you understand what the results mean for you and your family. Genetic counseling is particularly recommended if you have paraganglioma at a young age, if you have multiple tumors, if you have a family history of these tumors, or if you have other symptoms suggesting a genetic syndrome.^[9]

Diagnostics for Clinical Trial Qualification

When considering participation in clinical trials for paraganglioma, specific diagnostic criteria must be met to determine if you are eligible. Clinical trials are research studies that test new approaches to treating or managing medical conditions. For paraganglioma, these trials help researchers develop better treatments and understand more about how these tumors behave.^[3]

Before enrolling in a clinical trial, you will typically need to undergo comprehensive diagnostic testing to confirm your diagnosis and characterize your tumor. This includes the same blood and urine tests used for standard diagnosis to measure hormone levels. Researchers need to know whether your tumor is producing catecholamines because this can affect which treatments might work best for you.^[3]

Imaging studies are essential for clinical trial qualification because they provide detailed information about the location, size, and extent of your tumor. Most trials require recent imaging, often within a few weeks or months before enrollment. MRI, CT, and nuclear medicine scans help determine whether your paraganglioma is localized to one area or has spread to other parts of your body. This information is crucial because different trials may be designed for patients with localized disease versus those with spread or recurrent tumors.^[9]

Genetic testing may also be part of the qualification process for some clinical trials. Trials focusing on hereditary paraganglioma might specifically recruit patients with certain genetic mutations. Understanding your genetic status helps researchers study how different genetic forms of paraganglioma respond to various treatments. If you have not had genetic testing before considering a clinical trial, your research team may arrange for this testing as part of the screening process.^[3]

Documentation of your medical history, including previous treatments and how your tumor responded to them, is another standard requirement for clinical trial enrollment. If you have had surgery, radiation therapy, or other treatments for paraganglioma in the past, this information helps researchers understand whether you might benefit from the experimental approach being studied in the trial.^[3]

Some clinical trials may require additional specialized tests beyond standard diagnostic procedures. These might include specific types of blood tests, tissue biopsies if tumor tissue is accessible, or advanced imaging techniques. The research team will explain exactly what tests are needed and why they are important for the specific trial you are considering. All testing required for clinical trial qualification is designed to ensure patient safety and to help researchers collect accurate information about how the treatment works.^[3]